KLH in Clinical Trials

Clinical trials involving KLH. Details such as study status, design and investigators are available by link to outside sites.

Clinical trial links are intended for informational purposes only, and are not solicitations for any study nor provided for the purposes of giving medical advice. See Terms of Use for this site.

(in order by date)

Thursday
Jan192012

NCT01516307

Trial of Active Immunotherapy With Globo H-KLH (OPT-822) in Metastatic Breast Cancer Subjects

A Double-blind, Randomized Trial of Active Immunotherapy With Globo H-KLH (OPT-822) in Subjects With Metastatic Breast Cancer

Conditions: Metastatic Breast Cancer
Sponsors: OBI Pharma, Inc.
Phase II

Monday
Jan092012

NCT01509391

Keyhole Limpet Hemocyanin in Chronic Hepatitis C (IM1)

Conditions: Chronic Hepatitis C, Liver Cirrhosis
Sponsors: Medical University of Graz
Phase n/a

Monday
Jan092012

2011-004394-90

 Keyhole Limpet Hemocyanin in Chronic Hepatitis C and Compensated Cirrhosis - IM1

Conditions: Chronic Hepatitis C, Liver Cirrhosis
Sponsors: Medical University of Graz
Phase n/a

Wednesday
Dec212011

NCT01498328

A Study of Rindopepimut/GM-CSF in Patients With Relapsed EGFRvIII-Positive Glioblastoma (ReACT)

Conditions: Glioblastoma, Small Cell Glioblastoma, Giant Cell Glioblastoma, Gliosarcoma, Glioblastoma With Oligodendroglial Component
Sponsors: Celldex Therapeutics
Phase II

Thursday
Dec012011

NCT01489956

A Study to Determine the Immunogenicity and Oral Tolerance to Keyhole Limpet Hemocyanin (KLH)

Conditions: Autoimmune Disorders
Sponsors: National Institute of Allergy and Infectious Diseases (NIAID) 
Phase 0 completed

Monday
Nov212011

NCT01480479

Phase III Study of Rindopepimut/GM-CSF in Patients With Newly Diagnosed Glioblastoma (ACT IV)

Conditions: Glioblastoma, Small Cell Glioblastoma, Giant Cell Glioblastoma, Gliosarcoma, Glioblastoma With Oligodendroglial Component
Sponsors: Celldex Therapeutics
Phase III

Tuesday
Oct182011

NCT01456104

Tuesday
Aug302011

NCT01426828

Id-KLH Vaccine + T Cells

Conditions: Multiple Myeloma
Sponsors: Abramson Cancer Center of the University of Pennsylvania
Phase 2

Thursday
May052011

NCT01349647

Immunization With a Pentavalent Vaccine Composed of KLH-conjugates of GD2L, GD3L, Globo H, Fucosyl GM1, and N-Propionylated Polysialic Acid

Conditions: Lung Cancer
Sponsors: Memorial Sloan-Kettering Cancer Center, National Cancer Institute (NCI)
Phase: n/a 

Friday
Apr012011

NCT01329354

Rituximab and Autologous Effector Lymphocytes in Non-Hodgkins Follicular Lymphoma in Response to First Line Chemotherapy

Conditions: Non-Hodgkin Lymphoma
Sponsors: Clinica Universidad de Navarra, Universidad de Navarra
Phase: II